19 June 2013
Keywords: biovail, increases, revenue, guidance, canada, corp, increased
Article | 27 May 2002
Canada's Biovail Corp has increased its quarterly and total 2002 productsales revenue guidance, due to the acquisition of Vasotec (enalapril)
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
27 May 2002
18 June 2013
© 2013 thepharmaletter.com